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Floating thrombus in the ascending aorta: 
A rare cause of peripheral emboli 
Afksend iyos  Kalangos,  MD,  PhD,  Ary  Baldovinos,  MD,  C6dric Vuille, MD,  
Michel Montessui t ,  MD,  and Bernard  Faidutf i ,  MD,  Geneva, Switzerland 
The ascending aorta may be the site of  origin of  systemic embolization in some cases that 
do not have an identifiable source. We report a case in which a free-floating thrombus in 
the noncoronary sinus of  Valsalva was detected by transesophageal echocardiography as a 
source of  left axillary artery embolism. After removal of  this pedunculated thrombus of  
unknown cause, which was attached on a macroscopically and histologically normal 
aortic wall, the patient made an uneventfifl recovery. (J Vasc Surg 1997;26:150-4.)  
Although left cardiac chambers and aortic aneu- 
rysms are common sites o f  origin o f  systemic emboli, 
Darling and associates 1 reported in 1967 that 6% to 
13% of  patients with arterial embolism had no evi- 
dent source as a result o f  the inability to accurately 
determine unusual sites o f  origin o f  clots. However, 
since that time further technologic advances in imag- 
ing methods, and especially enhanced clinical appli- 
cation of  transesophageal echocardiography (TEE), 
have facilitated the detection and evaluation of  un- 
usual sites ofembol i  n the ascending aorta and aortic 
arch and thus lowered the incidence of  unapparent 
sources o f  systemic embolism. 2 We report a particu- 
larly interesting case in which a pedunculated ftee- 
floating thrombus in the ascending aorta of  un- 
known origin was attached to a normal aortic wall 
and was thought  to be the origin o f  a left axillary 
arterial embolic event. In addition, a review of  similar 
cases in the literature is presented. 
CASE REPORT 
A 39-year-old man was apparently in good health until 
he was admitted to our emergency department for sudden 
ischemia of the left arm. A left axillary artery occlusion was 
demonstrated by angi0graphic examination. The patient 
was treated successfully with a transbrachial embolectomy. 
The patient had no previous history of thrombotic events 
and had never been exposed to heparin. He was taking no 
medication. Histologic examination of the embolus dis- 
closed a fresh thrombus that was composed ofplatelets, red 
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blood cells, polymorphonuclear cells, and fibrin. No evi- 
dence of malignant cells was found. Physical examination, 
chest roentgenogram, electrocardiogram, and Holter 
monitoring showed no abnormalities. Two-dimensional 
transthoracic echocardiography (TEE) excluded pericardial 
effusion, mitral valve prolapse, stenosis, and the presence of 
thrombus in the left atrial appendage. The aortic valve was 
tricuspid without evidence of insufficiency, stenosis, or turbu- 
lent flow. The four cardiac hambers and the ascending aorta 
were of normal dimensions. Left and right ventricular wall 
thickness and contractility were normal. No patent foramen 
ovale was detected on the color Doppler echocardiogram. 
However, aTEE confirmed the findings of TTE but revealed 
the presence of a floating mass more than I cm in diameter in 
the noncoronary sinus of Valsalva (Fig. 1). 
Real-rime ultrasonic imaging and duplex scanning of 
the venous system of the lower limbs demonstrated com- 
petent valve cusps and no deep vein thrombosis. Labora- 
tory data were normal. A serial hematologic workup dem- 
onstrated a platelet count that Varied between 212,000 
mm 3 to 260,000 mm 3, and normal white and red blood 
cell counts. Further blood test results, including prothrom- 
bin time, partial thromboplastin time, fibrinogen, anti- 
thrombin III, protein C, protein S, complement systems, 
fibrin split products, plasminogen, and alpha-II-antiplas- 
min were within normal imits. No myeloproliferative dis- 
order or leukemogenic transformation was suspected in 
hematologic microscopic examination and studies. No ab- 
normal band ofplasminogen was obtained in immunoelec- 
trophoresis. Tissue plasminogen activator (t-PA) activity at 
rest and after venous occlusion was judged normal. Results 
of functional assays of antithrombin III were normal. An- 
tiphospholipid antibodies and VDRL were negative. Plate- 
let aggregation tests showed no abnormality. Results of 
activated protein C resistance test were normal. 
The patient underwent surgery urgently to prevent a 
recurrent embolic event, particularly brain embolization. 
The operation was conducted using cardiopulmonary b - 
pass with mild hypothermia (32 ° C). After aortic cross- 
clamping a transverse aortotomy was performed, and cold 
potassium cardioplegic solution was then injected selec- 
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Fig. 1. Preoperative transesophageal echocardiogram shows floating mass (arrow) in non- 
coronary sinus of  Valsalva. 
Tab le  I .  Repor ted  cases o f  f loat ing thrombus  or  mob i le  atherosclerot ic  debris in l i terature 
Clinical Diagnostic Site of 
Author Age Sex manifestation tool thrombus Treatment Outcome 
Heiskel, 1976 a 49 F Bilateral iliac artery Autopsy Asc Aorta 1.5 cm None Died 
emboli above AV 
Goebel, 19834 58 M Incidental detection Angiography Distal Asc. Aorta 
Sadony, 1988 s 46 M Left femoral and DSA-CT Scan Distal Asc. Aorta 
brachial emboli 
Farah, 19936 74 F CVA TEE 
Baumgarmer, 41 M 
19937 
Hanson, 19948 24 F TTE-TEE 
Muehrcke, 19969 68 M TTE 
Current study, 39 M TEE 
1996 
Left femoral and left DSA-CT Scan 
brachial emboli 
CVA 
CVA 
Left axillary emboli 
Asc. Aorta, 2 cm 
above AV 
Distal Asc. Aorta 
Lysis under anticoagulation TIA 
Removal under Uneventful 
cardiocirculatory 
arrest 
Lysis under anticoagulation Uneventful 
Removal under 
cardiocirculatory 
arrest 
Proximal Asc. Aorta Removal under simple 
aortic cross-clamping 
Distal Asc. Aorta Endarterectomy under 
cardiocirculatory arrest 
Noncoronary Removal under simple 
sinus of Valsalva aortic cross-clamping 
Uneventful 
Uneventful 
Uneventful 
Uneventful 
CVA, Cerebrovascular accident; DSA, digital subtraction angiography; CT scan, computed tomographic scan; TEE, transesophageal 
echocardiography; TEE, transthoracic e hocardiography; Asc. Aorta, ascending aorta; AV, aortic valve; TIA, transient ischemic attack. 
tively to both coronary ostia. A floating thrombus (1.5 × 1 
cm) was localized in the noncoronary sinus of  Valsalva. It 
was attached on the intima of the aortic wall about 8 mm 
superior to the level of  the aortic annulus by a small pedicle 
1 mm in diameter (Fig. 2). The aortic wall and leaflets 
appeared normal, and no macroscopic atherosclerotic 
changes were found on the site of  implantation of  this 
mass. The left ventricle was explored through the aortic 
valve and no thrombus was found. The mitral valve was 
intact. This mass was removed with a small button of  aortic 
wall surrounding its pedicle. 
Histologic examination of  the mass revealed a fresh 
thrombus that was composed of a fibrinous material with 
polymorphonuclcar cells, lymphocytes, and platelets. A 
histopathologic evaluation of  the aortic wall demonstrated 
no evidence ofatherosclerosis or other arterial wall disease. 
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Fig. 2. Intraoperative photograph shows floating throm- 
bus attached to noncoronary sinus of Valsalva aortic wall. 
Forceps in ascending aorta gently holds thrombus. 
No bacteria or fungus were present in serial histologic 
sections, and cultures of the mass yielded negative findings. 
An appropriate r gimen of anticoagulation therapy with an 
antivitamin K was started on the first day after surgery, and 
an international normalized ratio of 2 to 2.5 was main- 
tained to prevent recurrent clot formation. The patient is 
doing well 12 months after surgery without evidence of re- 
current aortic thrombus in echocardiographic controls. Sub- 
sequent serial hematologic and pl sma coagulation system 
tests in the follow-up period have not disclosed abnormalities. 
DISCUSSION 
Atrial fibrillation, myocardial infarction, rheu- 
matic and bacterial endocarditis, ventricular aneu- 
rysms, and prosthetic valves are potential cardiac 
causes of systemic embolization. On the other hand, 
the most frequent noncardiac sources are mural 
thrombi within proximal aneurysms, ulcerated ath- 
erosclerotic plaques and paradoxical emboli originat- 
ing from the venous side of the circulation. 
Floating masses in the ascending aorta are un- 
common sources of systemic embolism; only seven 
such cases have previously been reported in the liter- 
ature (Table I). The most frequent cause is athero- 
sclerosis of  the ascending aorta and mobile thrombi 
or atherosclerotic debris located 011 atherosderotic 
plaques? -7,9 In contrast, a floating thrombus with no 
evidence of  atherosclerotic ascending aorta has been 
seemingly implicated only in two cases of systemic 
embolism, including our patient, s This unusual and 
unexplained arterial or aortic thrombosis occurs at a 
young age and could be an indicator of a hyperco- 
agulable disorder. 1° The first reported case of as- 
cending aortic floating thrombus with no evidence of 
aortic atherosclerosis was a young woman who had 
systemic lupus erythematosus. 8 Thrombus formation 
has been speculated to be caused by a hypercoagu- 
lable state induced by her illness. In the majority of 
unexplained thrombotic events, clotting abnormali- 
ties could not be detected espite multiple current 
testing methods. 11 The diagnosis of a hypercoagu- 
lable state in our patient was excluded by the nega- 
tive complete coagulation profile and lack of previ- 
ously unexplained arterial or venous thromboses in 
himself and his family members. Moreover, the lack 
ofatherosclerotic r sk factors except smoking and the 
innocent histologic aspect of the ascending aortic 
wall have raised the question of unknown mecha- 
nisms in thrombus formation. Our suggestion is that 
the role of a transient hypercoagulable state that is 
not well understood at the present time, in a site such 
as the aortic sinus of Valsalva where turbulence could 
act as a contributing factor, remains a reasonable 
possibility. Current knowledge about the effect of 
alterations of local tissue plasminogen activator (t- 
PA), which is produced and released from vascular 
endothelium, and the counteraction of anti-t-PA is 
poorly established. However, several authors have 
suggested that reduced fibrinolytic potential as a re- 
sult of  a reduced capacity to release t-PA or to high 
levels of t-PA inhibitor could be evident risk factors 
for myocardial infarction and subsequent graft occlu- 
sion in patients who undergo aortocoronary bypass 
surgery. 12-14 
The second interesting feature of our case is the 
confirmation of the well-known advantage of TEE 
over TTE concerning the sensitivity to visualizing 
posterior structures such as the ascending aorta, aor- 
tic arch, and descending aorta. 8As was demonstrated 
by Pop and associates, i  TEE detects potential em- 
bolic sources in 20% more patients when compared 
with TTE. In addition, TEE is less invasive than 
conventional aortic angiographic examination, in 
which the risk of mobilizing the thrombus is greater. 
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However, computerized axial tomographic scans and 
digital subtraction angiographic evaluation seem also 
to be valuable tools in the identification of thrombi 
in the ascending aorta. 5,7 
The clinical presentation of floating thrombi or 
atherosclerotic debris in the ascending aorta is char- 
acterized by symptoms related to acute or chronic 
recurrent cerebrovascular or peripheral embolic 
events. Many authors reported that protruding athe- 
romas in the aortic arch and thoracic aorta as seen on 
TEE are strongly associated with systemic embolic 
events, the incidence of embolic events being higher 
when atheromas contain floating debris. 2,16-18 Natu- 
rally, those of the ascending aorta follow the same 
course, as was pointed out in the review of the liter- 
ature. 8-7,9 In addition, it is well known that athero- 
sclerosis of the ascending aorta is an incremental risk. 
factor for atheroemboli during open heart surgery. 19 
The treatment of patients who suffer from sys- 
temic embolic events and in whom a floating throm- 
bus or protruding atheroma has been detected re- 
mains problematic. We believe that the presence of 
an ascending aortic floating thrombus or mobile ath- 
erosclerotic debris in patients who have embolic 
events should prompt consideration for surgery. M- 
though the prevention of systemic embolism by the 
surgical debridement of the atherosclerotic ascend- 
ing aorta or aortic arch was initially recommended in 
patients who undergo planned cardiac surgery for 
reasons other than recurrent systemic embolism, the 
current tendency is to extend the indications for 
surgery in patients who otherwise would not have 
required cardiac operation but who had embolic 
events and in whom the risk of embolic brain infarc- 
tion is high. 9,2° 
Neither antiplatelet agents nor antivitamin K 
such as warfarin has been shown to effectively prevent 
recurrent embolic episodes from aortic atheromas. 2° 
On one hand, therapeutic anticoagulation may para- 
doxically induce further embolic events by causing 
plaque hemorrhage, particularly in the presence of 
protruding atheromas 21,22 or by lysing the thin pedi- 
cle of the thrombus more rapidly than the mass itself. 
On the other hand, the efficacy of the anticoagula- 
tion in the presence of mobile atherosclerotic debris 
is questionable. Despite successful lysis of ascending 
aortic thrombi with the patient under anticoagula- 
rion therapy in two reported cases, one of the pa- 
tients had a transient ischemic attack, probably as a 
result of  an embolic episode. 4 Moreover, patients are 
also exposed to complications associated with lysis 
therapy. However, therapeutic anticoagulation can 
be recommended routinely for the asymptomatic pa- 
tient in whom the risks of complex distal ascending 
aortic intervention may outweigh the benefits. 
The symptomatic patient in whom protruding 
atheromas of  high embolic potential are detected in 
the distal ascending aorta during diagnostic evalua- 
tions requires either endarterectomy or resection and 
grafting under hypothermic cardiocirculatory arrest ac- 
cording to the extent of atherosderofic disease. 5,7 
However, the risk ofneurologic damage isstill a poten- 
tial concern despite recent echnical improvements on 
cerebral protection during periods of circulatory arrest. 
In contrast, thrombi located in the proximal as- 
cending aorta with no evidence of aortic atheroscle- 
rosis are easily removed using cardiopulmonary by- 
pas s with simple aortic cross-clamping. The risk of 
such a surgical procedure can be considered low, as 
was confirmed by the rapid uneventful recovery in 
both reported cases, including our patient, s 
CONCLUSION 
A diligent search of  unusual sources of emboliza- 
tion should be tal~en into consideration during diag- 
nostic evaluation because today the majority of the 
sources are detectable and treatable, and recurrent 
systemic mbolism is hence preventablc. Medical ly- 
sis versus surgical debridement will require further 
investigations to determine the risk/benefit ratio. 
Systemic surveillance should be undertaken in cases 
of unexplained arterial thrombotic events, and pro- 
phylactic anticoagulation should be continued to de- 
crease the risk for repeat hrombotic omplications. 
Further research should be concentrated on poorly 
understood topical mechanisms of increased endothe- 
lial cell thrombotic tendency to better clarify reasons of 
unlmown arterial or venous thromboembolic events. 
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